Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Biphenotypic, Acute 2Graft vs Host Disease 2Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia 1Hodgkin Disease 1Anemia, Refractory 1

Interventions

Cyclophosphamide 9ruxolitinib 7Azacitidine 7fludarabine phosphate 6Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6Mycophenolic Acid 6navitoclax 5fludarabine 5Therapeutics 5Busulfan 5ponatinib 4Melphalan 4Tacrolimus 3Stem Cell Transplantation 3Patient Reported Outcome Measures 3Mesna 3Immunoenzyme Techniques 3Flow Cytometry 3Cyclosporine 3Clofarabine 3Antilymphocyte Serum 3vosaroxin 2trametinib 2liposomal amphotericin B 2dabrafenib 2Watchful Waiting 2Transplantation 2Sirolimus 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Abatacept × Myeloid × Clear all
NCT01012492 2019-11-21

Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT

Boston Children's Hospital

Phase 2 Completed
11 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Leukemia, Myelodysplastic Syndromes, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡